系统性硬化症眼部受累:一项系统文献综述
该系统综述按PRISMA指南检索3个电子数据库,从270篇文章中纳入9项病例对照研究,评估系统性硬化症(SSc)相关眼部改变。结果显示干眼症状与SSc相关,但Schirmer I试验等客观体征结果不一致,角膜中央厚度证据不足,脉络膜血管受累较视网膜微循环更明显,但纳入患者数量有限使结论受限。
要点
- 干眼症状与SSc相关,但Schirmer I试验等客观体征结果不一致。
- 脉络膜血管受累较视网膜微循环更明显。
- SSc相关眼部改变的高质量病例对照研究仍匮乏。
核心结论
- 设计良好的SSc眼部受累病例对照研究匮乏,SSc与眼部异常的确证关联有限,主要涉及干眼症状和脉络膜厚度。
研究设计与样本
- 按PRISMA指南检索3个电子数据库,由2名独立评审者在标题、摘要和全文层面筛选文献。
- 仅纳入比较SSc患者与健康对照者特定眼部表现的病例对照研究,最终纳入9项研究。
主要发现
- 干眼症状与SSc相关,而Schirmer I试验等客观体征结果不一致。
- SSc相关角膜中央厚度改变的证据不足。
- 后节段受累方面,脉络膜血管受影响程度较视网膜微循环更明显。
- 纳入研究的患者数量有限,难以得出总体结论。
关键数值与推荐
- 共筛选270篇文章,最终纳入9项病例对照研究。
- 纳入标准为比较SSc患者与健康对照者特定眼部表现的病例对照研究。
临床怎么用
- 对SSc患者应关注干眼症状,但Schirmer I试验等客观检查结果需谨慎解读。
- 评估SSc眼部受累时可关注脉络膜血管改变,视网膜微循环受累相对较轻。
局限性
- 纳入的病例对照研究数量少且患者数量有限,难以得出总体结论。
- 现有证据不足以明确SSc对角膜中央厚度等眼部参数的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Systemic sclerosis (SSc) is a rare and complex autoimmune disorder characterized by microvascular damage and progressive fibrosis which affects the skin and multiple other organs. Much of the published data concerning SSc and the eye consists of single case reports or small case studies. This systematic review aims to provide an overview of the current level of evidence for SSc-related ocular changes. MATERIALS AND METHODS: A systematic literature review was conducted using 3 electronic databases, according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. A combination of following keywords was used: "Systemic Sclerosis" and ophthalmology-related search terms, including the keywords "Eye", "Ocular" and "Ophthalmic". All articles were screened by 2 independent reviewers at title, abstract and full text level. We solely included case-control studies that investigated specific ocular findings in SSc patients compared to healthy controls. RESULTS: Nine of 270 articles were retained. Dry eye symptoms are associated with SSc, whereas objective signs (Schirmer I testing) show conflicting results. There is insufficient evidence of SSc-related changes to the central corneal thickness. In terms of posterior segment involvement, choroidal vasculature appears to be affected to greater extent than the retinal microcirculation. However, the limited number of patients included in the studies renders it hazardous to draw overall conclusions. CONCLUSIONS: There is a paucity of well-designed case-control studies investigating possible ocular involvement in SSc. Our systematic review demonstrates limited proven associations between SSc and ocular abnormalities, mainly in terms of dry eye symptoms and choroidal thickness. Future standardized prospective studies are needed to clarify the impact of the disease on the eye.
引用
- Kreps EO, Carton C, Cutolo M, et al. Ocular involvement in systemic sclerosis: A systematic literature review, it's not all scleroderma that meets the eye. Semin Arthritis Rheum. 2018. PMID: 30660382. doi:10.1016/j.semarthrit.2018.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。